Esperion Therapeutics (ESPR)

Trade ESPR now with
9/5/2019 7:49:06 AM Esperion Completes Patient Enrollment In Global CLEAR Cardiovascular Outcomes Trial For Bempedoic Acid
1/4/2019 7:04:29 AM Esperion Announces Agreement With Daiichi Sankyo Europe To Commercialize Bempedoic Acid In Europe
8/27/2018 7:04:30 AM Esperion Announces Positive Top-Line Results From Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill Study
8/25/2018 7:15:33 AM Esperion Announces Late-Breaking Oral Presentation Of Final Results Of Phase 3 Long-Term Safety Study Of Bempedoic Acid
8/2/2018 7:28:55 AM Esperion Q2 Net Loss $45.7 Mln Or $1.71 Per Share
5/23/2018 8:28:30 AM Esperion Therapeutics Trading Expected To Resume At 8:45 AM ET
5/23/2018 8:21:42 AM Esperion Says Third Pivotal Phase 3 Study Of Bempedoic Acid Meets Primary Endpoint
5/23/2018 8:12:54 AM Esperion Therapeutics Trading Halted; Pending News
5/2/2018 7:41:30 AM Esperion Therapeutics Trading Halted; Expected To Resume At 8:00 AM ET